JOSÉ LUIS
LOBO BERISTAIN
Ikertzailea 2023-(e)ra arte
Hospital Clínico San Carlos de Madrid
Madrid, EspañaHospital Clínico San Carlos de Madrid -ko ikertzaileekin lankidetzan egindako argitalpenak (10)
2023
2022
-
Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism
Cancers, Vol. 14, Núm. 17
-
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4
2021
-
Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989
-
Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial
JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285
2020
-
Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry
Journal of Vascular Surgery: Venous and Lymphatic Disorders, Vol. 8, Núm. 3, pp. 353-359.e1
2019
-
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Scientific Reports, Vol. 9, Núm. 1
-
Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry
Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1
-
The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease
Clinical Cardiology, Vol. 42, Núm. 3, pp. 346-351